Portal:RareDisease/FeaturedPathways

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Current revision (11:39, 2 June 2021) (view source)
 
(30 intermediate revisions not shown.)
Line 1: Line 1:
 +
== Rare diseases in general ==
{| style="margin: 10px"
{| style="margin: 10px"
-
|width=100px; cell padding=50px|{{#pwImage:Pathway:WP3584|250px||MECP2 and Associated Rett Syndrome (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP2059|250px||Alzheimers Disease}}
|width=100px|{{#pwImage:Pathway:WP2447|250px||Amyotrophic lateral sclerosis (ALS) (Homo sapiens)}}
|width=100px|{{#pwImage:Pathway:WP2447|250px||Amyotrophic lateral sclerosis (ALS) (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP3853|250px||ERK Pathway in Huntington's Disease}}
 +
|width=100px|{{#pwImage:Pathway:WP4803|250px||Ciliopathies}}
 +
|}
 +
{| style="margin: 10px"
|width=100px|{{#pwImage:Pathway:WP3569|250px||Fanconi Anemia Pathway (Homo sapiens)}}
|width=100px|{{#pwImage:Pathway:WP3569|250px||Fanconi Anemia Pathway (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4320|250px||The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP4549|250px||Fragile X Syndrome}}
-
|-
+
|width=100px|{{#pwImage:Pathway:WP4656|250px||Joubert Syndrome}}
-
|width=100px|{{#pwImage:Pathway:WP4299|250px||Lamin A-processing pathway (Homo sapiens)}}
+
|width=100px; cell padding=50px|{{#pwImage:Pathway:WP3584|250px||MECP2 and Associated Rett Syndrome (Homo sapiens)}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4540|250px||Pathways Regulating Hippo Signaling}}
 +
|width=100px|{{#pwImage:Pathway:WP2371|250px||Parkinsons Disease Pathway}}
 +
|width=100px|{{#pwImage:Pathway:WP4541|250px||po-Merlin Signaling Dysregulation}}
 +
|width=100px|{{#pwImage:Pathway:WP3995|250px||Prion disease pathway}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4312|250px||Rett syndrome causing genes}}
 +
|width=100px|{{#pwImage:Pathway:WP4746|250px||Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism}}
|width=100px|{{#pwImage:Pathway:WP4298|250px||Viral Acute Myocarditis (Homo sapiens)}}
|width=100px|{{#pwImage:Pathway:WP4298|250px||Viral Acute Myocarditis (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4156|250px||Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism}}
+
|width=100px|{{#pwImage:Pathway:WP4577|250px||Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway}}
-
|width=100px|{{#pwImage:Pathway:WP4506|250px||Tyrosine Metabolism}}
+
|}
|}
{| style="margin: 10px"
{| style="margin: 10px"
-
|width=100px|{{#pwImage:Pathway:WP4292|250px||Sulphur Amino Acids}}
+
|width=100px|{{#pwImage:Pathway:WP4947|250px||Nitric oxide metabolism in cystic fibrosis}}
-
|width=100px|{{#pwImage:Pathway:WP4259|250px||Disorders of Folate Metabolism and Transport}}
+
|width=100px|{{#pwImage:Pathway:WP5087|250px||Malignant pleural mesothelioma}}
-
|width=100px|{{#pwImage:Pathway:WP4288|250px||MTHFR deficiency (additonal pathway)}}
+
|width=100px|{{#pwImage:Pathway:WP4804|250px||Cholesterol biosynthesis with skeletal dysplasias}}
-
|width=100px|{{#pwImage:Pathway:WP4228|250px||Vitamine B6-Dependent and Responsive Disorders}}
+
|width=100px|{{#pwImage:Pathway:WP5114|250px||Nucleotide excision repair in xeroderma pigmentosum}}
|}
|}
 +
 +
== Copy number variation syndromes ==
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4905|250px||1q21.1 copy number variation syndrome}}
 +
|width=100px|{{#pwImage:Pathway:WP4906|250px||3q29 copy number variation syndrome}}
 +
|width=100px|{{#pwImage:Pathway:WP4657|250px||22q11.2 copy number variation syndrome}}
 +
|width=100px|{{#pwImage:Pathway:WP3998|250px||Prader-Willi and Angelman Syndrome}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4932|250px||7q11.23 copy number variation syndrome}}
 +
|width=100px|{{#pwImage:Pathway:WP4940|250px||15q11.2 copy number variation syndrome}}
 +
|width=100px|{{#pwImage:Pathway:WP4942|250px||15q13.3 copy number variation syndrome}}
 +
|width=100px|{{#pwImage:Pathway:WP4949|250px||16p11.2 proximal deletion syndrome}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4950|250px||16p11.2 distal deletion syndrome}}
 +
|}
 +
 +
== Laminopathies ==
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4879|250px||Interacting Laminopathic Pathways}}
 +
|width=100px|{{#pwImage:Pathway:WP4299|250px||Lamin A-processing pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP4320|250px||The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP4844|250px||The influence of laminopathies on Wnt signaling}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4535|250px||Envelope proteins and their potential roles in EDMD physiopathology}}
 +
|}
 +
 +
== Disorders of sex development ==
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4673|250px||Genes involved in male infertility}}
 +
|width=100px|{{#pwImage:Pathway:WP4871|250px||Kisspeptin/Kisspeptin Receptor System in the Ovary}}
 +
|width=100px|{{#pwImage:Pathway:WP4842|250px||Mammalian disorder of sexual development}}
 +
|width=100px|{{#pwImage:Pathway:WP4835|250px||Peroxiredoxin 2 induced ovarian failure}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4814|250px||Somatic Sex determination}}
 +
|width=100px|{{#pwImage:Pathway:WP4524|250px||The alternative pathway of fetal androgen synthesis}}
 +
|width=100px|{{#pwImage:Pathway:WP5074|250px||Kallmann syndrome}}
 +
|}
 +
== CAKUT (congenital anomalies of the kidney and urinary tract)==
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP5053|250px||Development of uretric collection system}}
 +
|width=100px|{{#pwImage:Pathway:WP4830|250px||GDNF/RET signalling axis}}
 +
|width=100px|{{#pwImage:Pathway:WP4823|250px||Genes controlling renal nephrogenesis}}
 +
|width=100px|{{#pwImage:Pathway:WP5052|250px||Nephrogenesis}}
 +
|}
 +
 +
== Lipodystrophy, dyslipidemia and hyperlipidemia ==
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP5105|250px||Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia}}
 +
|width=100px|{{#pwImage:Pathway:WP5108|250px||Familial hyperlipidemia type 1}}
 +
|width=100px|{{#pwImage:Pathway:WP5109|250px||Familial hyperlipidemia type 2}}
 +
|width=100px|{{#pwImage:Pathway:WP5110|250px||Familial hyperlipidemia type 3}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP5111|250px||Familial hyperlipidemia type 4}}
 +
|width=100px|{{#pwImage:Pathway:WP5112|250px||Familial hyperlipidemia type 5}}
 +
|width=100px|{{#pwImage:Pathway:WP5104|250px||Acquired partial lipodystrophy / Barraquer-Simons syndrome}}
 +
|width=100px|{{#pwImage:Pathway:WP5103|250px||Progeria-associated lipodystrophy}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP5102|250px||Familial partial lipodystrophy (FPLD)}}
 +
|width=100px|{{#pwImage:Pathway:WP5101|250px||Congenital generalized lipodystrophy (CGL)}}
 +
|}
 +
 +
== Inborn errors of metabolism ==
{| style="margin: 10px"
{| style="margin: 10px"
|width=100px|{{#pwImage:Pathway:WP4507|250px||Molybdenum (Moco) cofactor biosynthesis}}
|width=100px|{{#pwImage:Pathway:WP4507|250px||Molybdenum (Moco) cofactor biosynthesis}}
Line 21: Line 103:
|width=100px|{{#pwImage:Pathway:WP4271|250px||Vitamin B12 Disorders}}
|width=100px|{{#pwImage:Pathway:WP4271|250px||Vitamin B12 Disorders}}
|width=100px|{{#pwImage:Pathway:WP4297|250px||Thiamine Disorders}}
|width=100px|{{#pwImage:Pathway:WP4297|250px||Thiamine Disorders}}
 +
|}
 +
{| style="margin: 10px"
 +
|width=100px|{{#pwImage:Pathway:WP4292|250px||Methionine metabolism leading to sulfur amino acids and related disorders}}
 +
|width=100px|{{#pwImage:Pathway:WP4259|250px||Disorders of Folate Metabolism and Transport}}
 +
|width=100px|{{#pwImage:Pathway:WP4288|250px||MTHFR deficiency (additonal pathway)}}
 +
|width=100px|{{#pwImage:Pathway:WP4228|250px||Vitamine B6-Dependent and Responsive Disorders}}
|}
|}
{| style="margin: 10px"
{| style="margin: 10px"
|width=100px|{{#pwImage:Pathway:WP4236|250px||Disorders of the Krebs Cycle}}
|width=100px|{{#pwImage:Pathway:WP4236|250px||Disorders of the Krebs Cycle}}
-
|width=100px|{{#pwImage:Pathway:WP4153|250px||Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses}}
+
|width=100px|{{#pwImage:Pathway:WP4153|250px||Degradation pathway of sphingolipids, including diseases}}
|width=100px|{{#pwImage:Pathway:WP4220|250px||Neurotransmitter Disorders}}
|width=100px|{{#pwImage:Pathway:WP4220|250px||Neurotransmitter Disorders}}
|width=100px|{{#pwImage:Pathway:WP4224|250px||Purine Disorders}}
|width=100px|{{#pwImage:Pathway:WP4224|250px||Purine Disorders}}
Line 30: Line 118:
{| style="margin: 10px"
{| style="margin: 10px"
|width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}}
|width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}}
-
|width=100px|{{#pwImage:Pathway:WP4540|250px||Pathways Regulating Hippo Signaling}}
+
|width=100px|{{#pwImage:Pathway:WP4156|250px||Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism}}
-
|width=100px|{{#pwImage:Pathway:WP4541|250px||po-Merlin Signaling Dysregulation}}
+
|width=100px|{{#pwImage:Pathway:WP4506|250px||Tyrosine Metabolism}}
|width=100px|{{#pwImage:Pathway:WP4518|250px||Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases}}
|width=100px|{{#pwImage:Pathway:WP4518|250px||Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases}}
|}
|}
Line 41: Line 129:
|}
|}
{| style="margin: 10px"
{| style="margin: 10px"
-
|width=100px|{{#pwImage:Pathway:WP4524|250px||The alternative pathway of fetal androgen synthesis}}
+
|width=100px|{{#pwImage:Pathway:WP4792|250px||Purine metabolism}}
-
|width=100px|{{#pwImage:Pathway:WP4549|250px||Fragile X Syndrome}}
+
|width=100px|{{#pwImage:Pathway:WP4545|250px||Oxysterols derived from cholesterol}}
-
|width=100px|{{#pwImage:Pathway:WP4577|250px||WDR45 autophagy related pathway}}
+
|width=100px|{{#pwImage:Pathway:WP4595|250px||Urea cycle and associated pathways}}
-
|width=100px|{{#pwImage:Pathway:WP4312|250px||Rett syndrome causing genes}}
+
|width=100px|{{#pwImage:Pathway:WP5029|250px||Amino acid transport defects}}
|}
|}
{| style="margin: 10px"
{| style="margin: 10px"
-
|width=100px|{{#pwImage:Pathway:WP3995|250px||Prion disease pathway}}
+
|width=100px|{{#pwImage:Pathway:WP4686|250px||Leucine, isoleucine and valine metabolism}}
-
|width=100px|{{#pwImage:Pathway:WP4535|250px||Envelope proteins and their potential roles in EDMD physiopathology}}
+
|width=100px|{{#pwImage:Pathway:WP5028|250px||Glycine metabolism, including IEMs}}
-
|width=100px|{{#pwImage:Pathway:WP2371|250px||Parkinsons Disease Pathway}}
+
|width=100px|{{#pwImage:Pathway:WP4157|250px||GABA metabolism (aka GHB)}}
-
|width=100px|{{#pwImage:Pathway:WP2059|250px||Alzheimers Disease}}
+
|width=100px|{{#pwImage:Pathway:WP5026|250px||Proline and hydroxyproline pathways}}
|}
|}
{| style="margin: 10px"
{| style="margin: 10px"
-
|width=100px|{{#pwImage:Pathway:WP3853|250px||ERK Pathway in Huntington's Disease}}
+
|width=100px|{{#pwImage:Pathway:WP4686|250px||Leucine, isoleucine and valine metabolism}}
-
|width=100px|{{#pwImage:Pathway:WP4657|250px||22q11.2 Deletion Syndrome}}
+
|width=100px|{{#pwImage:Pathway:WP5028|250px||Glycine metabolism, including IEMs}}
-
|width=100px|{{#pwImage:Pathway:WP4656|250px||Joubert Syndrome}}
+
|width=100px|{{#pwImage:Pathway:WP4157|250px||GABA metabolism (aka GHB)}}
-
|width=100px|{{#pwImage:Pathway:WP4746|250px||Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism}}
+
|width=100px|{{#pwImage:Pathway:WP5026|250px||Proline and hydroxyproline pathways}}
|}
|}
{| style="margin: 10px"
{| style="margin: 10px"
-
|width=100px|{{#pwImage:Pathway:WP4673|250px||Genes involved in male infertility}}
+
|width=100px|{{#pwImage:Pathway:WP4688|250px||Serine metabolism}}
-
|width=100px|{{#pwImage:Pathway:WP4844|250px||The influence of laminopathies on Wnt signaling}}
+
|width=100px|{{#pwImage:Pathway:WP5031|250px||Biotin metabolism, including IEMs}}
-
|width=100px|{{#pwImage:Pathway:WP4842|250px||Mammalian disorder of sexual development}}
+
|width=100px|{{#pwImage:Pathway:WP5037|250px||Riboflavin and CoQ disorders}}
-
|width=100px|{{#pwImage:Pathway:WP4841|250px||Kisspeptin/Kisspeptin Receptor System in the Ovary}}
+
|width=100px|{{#pwImage:Pathway:WP4971|250px||Phosphoinositides metabolism}}
|}
|}
{| style="margin: 10px"
{| style="margin: 10px"
-
|width=100px|{{#pwImage:Pathway:WP4838|250px||Regucalcin in proximal tubule epithelial kidney cells}}
+
|width=100px|{{#pwImage:Pathway:WP5030|250px||Ethylmalonic encephalopathy}}
-
|width=100px|{{#pwImage:Pathway:WP4835|250px||Peroxiredoxin 2 induced ovarian failure}}
+
-
|width=100px|{{#pwImage:Pathway:WP4830|250px||GDNF/RET signalling axis}}
+
-
|width=100px|{{#pwImage:Pathway:WP4792|250px||Purine metabolism}}
+
-
|}
+
-
{| style="margin: 10px"
+
-
|width=100px|{{#pwImage:Pathway:WP4818|250px||Conversion of Angiotensinogen to Angiotensin II}}
+
-
|width=100px|{{#pwImage:Pathway:WP4823|250px||Genes controlling renal nephrogenesis}}
+
-
|width=100px|{{#pwImage:Pathway:WP4814|250px||Somatic Sex determination}}
+
-
|width=100px|{{#pwImage:Pathway:WP4905|250px||1q21.1 copy number variation syndrome}}
+
-
|}
+
-
{| style="margin: 10px"
+
-
|width=100px|{{#pwImage:Pathway:WP4906|250px||3q29 copy number variation syndrome}}
+
|}
|}
List of featured pathways:
List of featured pathways:
-
* [[Pathway:WP3584]] - MECP2 and Associated Rett Syndrome
+
* [[Pathway:WP2059]] - Alzheimers Disease
 +
* [[Pathway:WP2371]] - Parkinsons Disease Pathway
* [[Pathway:WP2447]] - Amyotrophic lateral sclerosis (ALS)
* [[Pathway:WP2447]] - Amyotrophic lateral sclerosis (ALS)
* [[Pathway:WP3569]] - Fanconi Anemia Pathway
* [[Pathway:WP3569]] - Fanconi Anemia Pathway
-
* [[Pathway:WP4320]] - The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome
+
* [[Pathway:WP3584]] - MECP2 and Associated Rett Syndrome
-
* [[Pathway:WP4299]] - Lamin A-processing pathway
+
* [[Pathway:WP3853]] - ERK Pathway in Huntington's Disease
-
* [[Pathway:WP4298]] - Viral Acute Myocarditis
+
* [[Pathway:WP3995]] - Prion disease pathway
 +
* [[Pathway:WP3998]] - Prader-Willi and Angelman Syndrome
 +
* [[Pathway:WP4153]] - Degradation pathway of sphingolipids, including diseases
* [[Pathway:WP4156]] - Disorders of Phenylalanine and Tetrahydrobiopterin
* [[Pathway:WP4156]] - Disorders of Phenylalanine and Tetrahydrobiopterin
-
* [[Pathway:WP4506]] - Tyrosine Metabolism
+
* [[Pathway:WP4157]] - GABA metabolism (aka GHB)
-
* [[Pathway:WP4292]] - Sulphur Amino Acids
+
-
* [[Pathway:WP4259]] - Disorders of Folate Metabolism and Transport
+
-
* [[Pathway:WP4288]] - MTHFR deficiency
+
-
* [[Pathway:WP4228]] - Vitamine B6-Dependent and Responsive Disorders
+
-
* [[Pathway:WP4507]] - Molybdenum (Moco) cofactor biosynthesis
+
-
* [[Pathway:WP4504]] - Cysteine and Methionine catabolism
+
-
* [[Pathway:WP4271]] - Vitamin B12 Disorders
+
-
* [[Pathway:WP4297]] - Thiamine Disorders
+
-
* [[Pathway:WP4236]] - Disorders of the Krebs Cycle
+
-
* [[Pathway:WP4153]] - Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses
+
* [[Pathway:WP4220]] - Neurotransmitter Disorders
* [[Pathway:WP4220]] - Neurotransmitter Disorders
* [[Pathway:WP4224]] - Purine Disorders
* [[Pathway:WP4224]] - Purine Disorders
* [[Pathway:WP4225]] - Pyrimidine Disorder
* [[Pathway:WP4225]] - Pyrimidine Disorder
-
* [[Pathway:WP4540]] - Pathways Regulating Hippo Signaling
+
* [[Pathway:WP4228]] - Vitamine B6-Dependent and Responsive Disorders
-
* [[Pathway:WP4541]] - po-Merlin Signaling Dysregulation
+
* [[Pathway:WP4236]] - Disorders of the Krebs Cycle
 +
* [[Pathway:WP4259]] - Disorders of Folate Metabolism and Transport
 +
* [[Pathway:WP4271]] - Vitamin B12 Disorders
 +
* [[Pathway:WP4288]] - MTHFR deficiency
 +
* [[Pathway:WP4292]] - Methionine metabolism leading to sulfur amino acids and related disorders
 +
* [[Pathway:WP4297]] - Thiamine Disorders
 +
* [[Pathway:WP4298]] - Viral Acute Myocarditis
 +
* [[Pathway:WP4299]] - Lamin A-processing pathway
 +
* [[Pathway:WP4312]] - Rett syndrome causing genes
 +
* [[Pathway:WP4320]] - The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome
 +
* [[Pathway:WP4504]] - Cysteine and Methionine catabolism
 +
* [[Pathway:WP4506]] - Tyrosine Metabolism
 +
* [[Pathway:WP4507]] - Molybdenum (Moco) cofactor biosynthesis
* [[Pathway:WP4518]] - Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases
* [[Pathway:WP4518]] - Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases
* [[Pathway:WP4519]] - Cerebral Organic Acidurias
* [[Pathway:WP4519]] - Cerebral Organic Acidurias
Line 110: Line 191:
* [[Pathway:WP4523]] - Classical pathway of steroidogenesis, including diseases
* [[Pathway:WP4523]] - Classical pathway of steroidogenesis, including diseases
* [[Pathway:WP4524]] - The alternative pathway of fetal androgen synthesis
* [[Pathway:WP4524]] - The alternative pathway of fetal androgen synthesis
-
* [[Pathway:WP4549]] - Fragile X Syndrome
 
-
* [[Pathway:WP4577]] - WDR45 autophagy related pathway
 
-
* [[Pathway:WP4312]] - Rett syndrome causing genes
 
-
* [[Pathway:WP3995]] - Prion disease pathway
 
-
* [[Pathway:WP3853]] - ERK Pathway in Huntington's Disease
 
* [[Pathway:WP4535]] - Envelope proteins and their potential roles in EDMD physiopathology
* [[Pathway:WP4535]] - Envelope proteins and their potential roles in EDMD physiopathology
-
* [[Pathway:WP2371]] - Parkinsons Disease Pathway
+
* [[Pathway:WP4540]] - Pathways Regulating Hippo Signaling
-
* [[Pathway:WP2059]] - Alzheimers Disease
+
* [[Pathway:WP4541]] - po-Merlin Signaling Dysregulation
-
* [[Pathway:WP4657]] - 22q11.2 Deletion Syndrome
+
* [[Pathway:WP4545]] - Oxysterols derived from cholesterol
 +
* [[Pathway:WP4549]] - Fragile X Syndrome
 +
* [[Pathway:WP4577]] - Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway
 +
* [[Pathway:WP4595]] - Urea cycle and associated pathways
* [[Pathway:WP4656]] - Joubert Syndrome
* [[Pathway:WP4656]] - Joubert Syndrome
-
* [[Pathway:WP4746]] - Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism
+
* [[Pathway:WP4657]] - 22q11.2 Deletion Syndrome
* [[Pathway:WP4673]] - Genes involved in male infertility
* [[Pathway:WP4673]] - Genes involved in male infertility
-
* [[Pathway:WP4844]] - The influence of laminopathies on Wnt signaling
+
* [[Pathway:WP4686]] - Leucine, isoleucine and valine metabolism
-
* [[Pathway:WP4842]] - Mammalian disorder of sexual development
+
* [[Pathway:WP4688]] - Serine metabolism
-
* [[Pathway:WP4841]] - Kisspeptin/Kisspeptin Receptor System in the Ovary
+
* [[Pathway:WP4746]] - Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism
-
* [[Pathway:WP4838]] - Regucalcin in proximal tubule epithelial kidney cells
+
-
* [[Pathway:WP4835]] - Peroxiredoxin 2 induced ovarian failure
+
-
* [[Pathway:WP4830]] - GDNF/RET signalling axis
+
-
* [[Pathway:WP4818]] - Conversion of Angiotensinogen to Angiotensin II
+
* [[Pathway:WP4792]] - Purine metabolism
* [[Pathway:WP4792]] - Purine metabolism
-
* [[Pathway:WP4823]] - Genes controlling renal nephrogenesis
+
* [[Pathway:WP4803]] - Ciliopathies
 +
* [[Pathway:WP4804]] - Cholesterol biosynthesis with skeletal dysplasias
* [[Pathway:WP4814]] - Somatic Sex determination
* [[Pathway:WP4814]] - Somatic Sex determination
 +
* [[Pathway:WP4823]] - Genes controlling renal nephrogenesis
 +
* [[Pathway:WP4830]] - GDNF/RET signalling axis
 +
* [[Pathway:WP4835]] - Peroxiredoxin 2 induced ovarian failure
 +
* [[Pathway:WP4842]] - Mammalian disorder of sexual development
 +
* [[Pathway:WP4844]] - The influence of laminopathies on Wnt signaling
 +
* [[Pathway:WP4871]] - Kisspeptin/Kisspeptin Receptor System in the Ovary
 +
* [[Pathway:WP4879]] - Interacting Laminopathic Pathways
* [[Pathway:WP4905]] - 1q21.1 copy number variation syndrome
* [[Pathway:WP4905]] - 1q21.1 copy number variation syndrome
* [[Pathway:WP4906]] - 3q29 copy number variation syndrome
* [[Pathway:WP4906]] - 3q29 copy number variation syndrome
 +
* [[Pathway:WP4932]] - 7q11.23 copy number variation syndrome
 +
* [[Pathway:WP4940]] - 15q11.2 copy number variation syndrome
 +
* [[Pathway:WP4942]] - 15q13.3 copy number variation syndrome
 +
* [[Pathway:WP4947]] - Nitric oxide metabolism in cystic fibrosis
 +
* [[Pathway:WP4949]] - 16p11.2 proximal deletion syndrome
 +
* [[Pathway:WP4950]] - 16p11.2 distal deletion syndrome
 +
* [[Pathway:WP4971]] - Phosphoinositides metabolism
 +
* [[Pathway:WP5026]] - Proline and hydroxyproline pathways
 +
* [[Pathway:WP5028]] - Glycine metabolism, including IEMs
 +
* [[Pathway:WP5029]] - Amino acid transport defects
 +
* [[Pathway:WP5030]] - Ethylmalonic encephalopathy
 +
* [[Pathway:WP5031]] - Biotin metabolism, including IEMs
 +
* [[Pathway:WP5037]] - Riboflavin and CoQ disorders
 +
* [[Pathway:WP5052]] - Nephrogenesis
 +
* [[Pathway:WP5053]] - Development of uretric collection system
 +
* [[Pathway:WP5074]] - Kallmann syndrome
 +
* [[Pathway:WP5087]] - Malignant pleural mesothelioma
 +
* [[Pathway:WP5101]] - Congenital generalized lipodystrophy (CGL)
 +
* [[Pathway:WP5102]] - Familial partial lipodystrophy (FPLD)
 +
* [[Pathway:WP5103]] - Progeria-associated lipodystrophy
 +
* [[Pathway:WP5104]] - Acquired partial lipodystrophy / Barraquer-Simons syndrome
 +
* [[Pathway:WP5105]] - Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia
 +
* [[Pathway:WP5108]] - Familial hyperlipidemia type 1
 +
* [[Pathway:WP5109]] - Familial hyperlipidemia type 2
 +
* [[Pathway:WP5110]] - Familial hyperlipidemia type 3
 +
* [[Pathway:WP5111]] - Familial hyperlipidemia type 4
 +
* [[Pathway:WP5112]] - Familial hyperlipidemia type 5
 +
* [[Pathway:WP5114]] - Nucleotide excision repair in xeroderma pigmentosum

Current revision

Contents

Rare diseases in general

Image does not exist
Alzheimers Disease
Image does not exist
Amyotrophic lateral sclerosis (ALS) (Homo sapiens)
Image does not exist
ERK Pathway in Huntington's Disease
Image does not exist
Ciliopathies
Image does not exist
Fanconi Anemia Pathway (Homo sapiens)
Image does not exist
Fragile X Syndrome
Image does not exist
Joubert Syndrome
Image does not exist
MECP2 and Associated Rett Syndrome (Homo sapiens)
Image does not exist
Pathways Regulating Hippo Signaling
Image does not exist
Parkinsons Disease Pathway
Image does not exist
po-Merlin Signaling Dysregulation
Image does not exist
Prion disease pathway
Image does not exist
Rett syndrome causing genes
Image does not exist
Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism
Image does not exist
Viral Acute Myocarditis (Homo sapiens)
Image does not exist
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway
Image does not exist
Nitric oxide metabolism in cystic fibrosis
Image does not exist
Malignant pleural mesothelioma
Image does not exist
Cholesterol biosynthesis with skeletal dysplasias
Image does not exist
Nucleotide excision repair in xeroderma pigmentosum

Copy number variation syndromes

Image does not exist
1q21.1 copy number variation syndrome
Image does not exist
3q29 copy number variation syndrome
Image does not exist
22q11.2 copy number variation syndrome
Image does not exist
Prader-Willi and Angelman Syndrome
Image does not exist
7q11.23 copy number variation syndrome
Image does not exist
15q11.2 copy number variation syndrome
Image does not exist
15q13.3 copy number variation syndrome
Image does not exist
16p11.2 proximal deletion syndrome
Image does not exist
16p11.2 distal deletion syndrome

Laminopathies

Image does not exist
Interacting Laminopathic Pathways
Image does not exist
Lamin A-processing pathway (Homo sapiens)
Image does not exist
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome (Homo sapiens)
Image does not exist
The influence of laminopathies on Wnt signaling
Image does not exist
Envelope proteins and their potential roles in EDMD physiopathology

Disorders of sex development

Image does not exist
Genes involved in male infertility
Image does not exist
Kisspeptin/Kisspeptin Receptor System in the Ovary
Image does not exist
Mammalian disorder of sexual development
Image does not exist
Peroxiredoxin 2 induced ovarian failure
Image does not exist
Somatic Sex determination
Image does not exist
The alternative pathway of fetal androgen synthesis
Image does not exist
Kallmann syndrome

CAKUT (congenital anomalies of the kidney and urinary tract)

Image does not exist
Development of uretric collection system
Image does not exist
GDNF/RET signalling axis
Image does not exist
Genes controlling renal nephrogenesis
Image does not exist
Nephrogenesis

Lipodystrophy, dyslipidemia and hyperlipidemia

Image does not exist
Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia
Image does not exist
Familial hyperlipidemia type 1
Image does not exist
Familial hyperlipidemia type 2
Image does not exist
Familial hyperlipidemia type 3
Image does not exist
Familial hyperlipidemia type 4
Image does not exist
Familial hyperlipidemia type 5
Image does not exist
Acquired partial lipodystrophy / Barraquer-Simons syndrome
Image does not exist
Progeria-associated lipodystrophy
Image does not exist
Familial partial lipodystrophy (FPLD)
Image does not exist
Congenital generalized lipodystrophy (CGL)

Inborn errors of metabolism

Image does not exist
Molybdenum (Moco) cofactor biosynthesis
Image does not exist
Cysteine and Methionine catabolism
Image does not exist
Vitamin B12 Disorders
Image does not exist
Thiamine Disorders
Image does not exist
Methionine metabolism leading to sulfur amino acids and related disorders
Image does not exist
Disorders of Folate Metabolism and Transport
Image does not exist
MTHFR deficiency (additonal pathway)
Image does not exist
Vitamine B6-Dependent and Responsive Disorders
Image does not exist
Disorders of the Krebs Cycle
Image does not exist
Degradation pathway of sphingolipids, including diseases
Image does not exist
Neurotransmitter Disorders
Image does not exist
Purine Disorders
Image does not exist
Pyrimidine Disorders
Image does not exist
Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism
Image does not exist
Tyrosine Metabolism
Image does not exist
Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases
Image does not exist
Cerebral Organic Acidurias
Image does not exist
Glycosylation and related congenital defects
Image does not exist
Metabolic pathway of LDL, HDL and TG
Image does not exist
Classical pathway of steroidogenesis, including diseases
Image does not exist
Purine metabolism
Image does not exist
Oxysterols derived from cholesterol
Image does not exist
Urea cycle and associated pathways
Image does not exist
Amino acid transport defects
Image does not exist
Leucine, isoleucine and valine metabolism
Image does not exist
Glycine metabolism, including IEMs
Image does not exist
GABA metabolism (aka GHB)
Image does not exist
Proline and hydroxyproline pathways
Image does not exist
Leucine, isoleucine and valine metabolism
Image does not exist
Glycine metabolism, including IEMs
Image does not exist
GABA metabolism (aka GHB)
Image does not exist
Proline and hydroxyproline pathways
Image does not exist
Serine metabolism
Image does not exist
Biotin metabolism, including IEMs
Image does not exist
Riboflavin and CoQ disorders
Image does not exist
Phosphoinositides metabolism
Image does not exist
Ethylmalonic encephalopathy

List of featured pathways:

Retrieved from "https://classic.wikipathways.org/index.php/Portal:RareDisease/FeaturedPathways"
Personal tools